Inventiva SA (NAS:IVA)
$ 3.48 -0.23 (-6.36%) Market Cap: 822.05 Mil Enterprise Value: 619.36 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 40/100

Inventiva SA Guggenheim Emerging Outlook: Biotech Summit 2026 Transcript

Feb 11, 2026 / 06:00 PM GMT
Release Date Price: $6.19 (-1.59%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

IVAA.PA - Inventiva SA
Inventiva SA Guggenheim Emerging Outlook: Biotech Summit 2026
Feb 11, 2026 / 06:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon everybody and thanks so much for joining us at another of our fireside chats here at Guggenheim's Emerging Outlook biotech conference. We host this conference annually and I'm really pleased to be joined by Inventiva again. CEO Andrew Obenshein is here with us today.

And you know Andrew, maybe I'll just kick it off very quickly to note, our previous company that was just up here has a phase 3 study reading out, and I think uniquely within our coverage you guys also have a phase 3 study reading out which is not.

In biotech, so really exciting to kind of have that opportunity to see that card get turned over this year in mash, but you know maybe you can just help us level set the level set
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot